Total circulating β2GPI levels were found to be significantly higher in APS patients with a history of thrombosis than they were in healthy controls and patients with autoimmune disease other than APS, while the level of reduced-β2GPI was significantly lower [7]. This evidence concerns the gene APOH and autoimmune polyendocrinopathy.